Pharmacologic management of HCV treatment in patients with HCV monoinfection vs. HIV/HCV coinfection: Does coinfection really matter?
<h4>Introduction</h4>Sustained virologic response (SVR) rates in patients with hepatitis C virus (HCV) monoinfection and human immunodeficiency virus (HIV)/HCV coinfection treated with direct acting antiviral (DAA) therapy are similar in clinical trials. The objective of this study was t...
Main Authors: | Autumn D Zuckerman, Andrew Douglas, Kristen Whelchel, Leena Choi, Joshua DeClercq, Cody A Chastain |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0225434 |
Similar Items
-
Pangenotypic and Genotype-Specific Antivirals in the Treatment of HCV Genotype 4 Infected Patients with HCV Monoinfection and HIV/HCV Coinfection
by: Dorota Zarębska-Michaluk, et al.
Published: (2022-01-01) -
Cellular activation and intracellular HCV load in peripheral blood monocytes isolated from HCV monoinfected and HIV-HCV coinfected patients.
by: Isabelle Dichamp, et al.
Published: (2014-01-01) -
Longitudinal Assessment of Multiple Immunological and Inflammatory Parameters during Successful DAA Therapy in HCV Monoinfected and HIV/HCV Coinfected Subjects
by: Paola Zuccalà, et al.
Published: (2022-10-01) -
Clinical Relevance of Torque Teno Virus (TTV) in HIV/HCV Coinfected and HCV Monoinfected Patients Treated with Direct-Acting Antiviral Therapy
by: Daniele Lapa, et al.
Published: (2021-05-01) -
Treatment of HBV–HCV coinfection
by: Rocío Torres Ibarra
Published: (2006-01-01)